DocuSign falls 0.5% as earnings loom after Jefferies downgrade
Technology

DocuSign falls 0.5% as earnings loom after Jefferies downgrade

Analyst cites AI concerns as price target slashed to $45, stock trades near 52-week low

DocuSign shares declined 0.5% to $46.82 on Tuesday as the electronic signature provider prepares to report fourth-quarter fiscal 2026 earnings after market close, with analysts expecting earnings per share of 95 cents on revenue of $828.22 million.

The company's stock has been under pressure following a significant downgrade from Jefferies on February 23, when analyst Brent Thill cut his rating from Buy to Hold and slashed the price target from $105 to $45. Thill cited concerns related to artificial intelligence and the belief that a significant re-acceleration in DocuSign's growth would be prolonged. The analyst also noted that the company's Intelligent Agreement Management (IAM) platform "needs to prove itself."

The Jefferies downgrade was part of a broader move by the firm to downgrade several enterprise software companies, including Workday, monday.com, and Freshworks, all attributed to AI-related fears. Following the downgrade, DocuSign's shares dropped to a new 52-week low, currently trading well below the stock's 52-week high of $94.67.

DocuSign is not alone in facing analyst skepticism. In December 2025, Wedbush analyst Daniel Ives maintained a Neutral rating while decreasing the price target from $85 to $75. Piper Sandler analyst Rob Owens also kept a Neutral rating and cut the price target from $90 to $75, while UBS analyst Karl Keirstead maintained a Neutral stance and reduced the price target from $85 to $75. RBC Capital analyst Rishi Jaluria lowered the price target from $95 to $70 on January 5, 2026, while maintaining a Sector Perform rating.

Earlier in December 2025, Bank of America reduced its price target for DocuSign from $102 to $82 with a neutral rating, and Wells Fargo cut its price objective from $85 to $75 with an equal weight rating.

Despite the recent wave of downgrades, the consensus analyst target price for DocuSign remains at $78.28, well above the current trading level. The stock currently trades at a trailing price-to-earnings ratio of 32.9 but a forward P/E of just 11.25, suggesting analysts expect significant earnings improvement. The company's market capitalization stands at $9.4 billion.

For the fourth quarter, analysts project earnings of $0.95 per share, representing a 10.5% increase compared to the $0.86 reported in the same quarter last year. Revenue is forecast to grow 6.6% year-over-year to $827.33 million. This follows DocuSign's third-quarter fiscal 2026 earnings, reported on December 4, 2025, which showed an actual EPS of $1.01, significantly surpassing the analyst consensus estimate of $0.68.

The Jefferies downgrade reflects broader concerns about how artificial intelligence might impact DocuSign's core business model. As enterprises increasingly deploy AI-powered solutions for document processing and contract management, investors are questioning whether DocuSign's traditional electronic signature business can maintain its growth trajectory or face competitive pressure from newer AI-first approaches.

DocuSign's IAM platform, which the company has positioned as its next-generation solution, will likely be a focal point during the earnings call. Analystysts will be watching for any updates on adoption rates, customer feedback, and how the platform is contributing to overall growth metrics.

The company's valuation metrics suggest some pessimism may already be priced in. With the stock trading near its 52-week low of $40.16 and well below analyst targets, much of the negative sentiment may be reflected in the current share price. However, the forward P/E of 11.25 indicates that investors expect earnings to accelerate from current levels.

Investors will be particularly focused on management's guidance for fiscal 2027, which will provide insight into whether the company believes it can reignite growth. Given the recent analyst downgrades and AI-related concerns, any signs of slowing momentum or cautious outlook could pressure shares further, while strong execution and upbeat guidance could provide a catalyst for a rebound.